These terms and conditions govern your use of the website alphaminr.com and its related services.
These Terms and Conditions (“Terms”) are a binding contract between you and Alphaminr, (“Alphaminr”, “we”, “us” and “service”). You must agree to and accept the Terms. These Terms include the provisions in this document as well as those in the Privacy Policy. These terms may be modified at any time.
Your subscription will be on a month to month basis and automatically renew every month. You may terminate your subscription at any time through your account.
We will provide you with advance notice of any change in fees.
You represent that you are of legal age to form a binding contract. You are responsible for any
activity associated with your account. The account can be logged in at only one computer at a
time.
The Services are intended for your own individual use. You shall only use the Services in a
manner that complies with all laws. You may not use any automated software, spider or system to
scrape data from Alphaminr.
Alphaminr is not a financial advisor and does not provide financial advice of any kind. The service is provided “As is”. The materials and information accessible through the Service are solely for informational purposes. While we strive to provide good information and data, we make no guarantee or warranty as to its accuracy.
TO THE EXTENT PERMITTED BY APPLICABLE LAW, UNDER NO CIRCUMSTANCES SHALL ALPHAMINR BE LIABLE TO YOU FOR DAMAGES OF ANY KIND, INCLUDING DAMAGES FOR INVESTMENT LOSSES, LOSS OF DATA, OR ACCURACY OF DATA, OR FOR ANY AMOUNT, IN THE AGGREGATE, IN EXCESS OF THE GREATER OF (1) FIFTY DOLLARS OR (2) THE AMOUNTS PAID BY YOU TO ALPHAMINR IN THE SIX MONTH PERIOD PRECEDING THIS APPLICABLE CLAIM. SOME STATES DO NOT ALLOW THE EXCLUSION OR LIMITATION OF INCIDENTAL OR CONSEQUENTIAL OR CERTAIN OTHER DAMAGES, SO THE ABOVE LIMITATION AND EXCLUSIONS MAY NOT APPLY TO YOU.
If any provision of these Terms is found to be invalid under any applicable law, such provision shall not affect the validity or enforceability of the remaining provisions herein.
This privacy policy describes how we (“Alphaminr”) collect, use, share and protect your personal information when we provide our service (“Service”). This Privacy Policy explains how information is collected about you either directly or indirectly. By using our service, you acknowledge the terms of this Privacy Notice. If you do not agree to the terms of this Privacy Policy, please do not use our Service. You should contact us if you have questions about it. We may modify this Privacy Policy periodically.
When you register for our Service, we collect information from you such as your name, email address and credit card information.
Like many other websites we use “cookies”, which are small text files that are stored on your computer or other device that record your preferences and actions, including how you use the website. You can set your browser or device to refuse all cookies or to alert you when a cookie is being sent. If you delete your cookies, if you opt-out from cookies, some Services may not function properly. We collect information when you use our Service. This includes which pages you visit.
We use Google Analytics and we use Stripe for payment processing. We will not share the information we collect with third parties for promotional purposes. We may share personal information with law enforcement as required or permitted by law.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
þ
|
|
ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
|
|
o
|
|
TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
|
|
Delaware
|
04-3536131
|
|
(State or Other Jurisdiction of Incorporation or Organization)
|
(IRS Employer Identification No.)
|
|
45 First Avenue
|
|
|
Waltham, Massachusetts
|
02451
|
|
(Address of Principal Executive Offices)
|
(Zip Code)
|
|
Title of each class
|
Name of each exchange on which registered
|
|
Common Stock, $0.001 par value
|
NASDAQ Capital Market
|
|
|
|
Item 1A.
|
Risk Factors.
|
|
|
Item 1B.
|
Unresolved Staff Comments.
|
|
|
Item 2.
|
Properties.
|
|
|
Item 3.
|
Legal Proceedings.
|
|
|
Item 4.
|
Mine Safety Disclosures.
|
|
|
|
|
|
|
PART II
|
||
|
|
|
|
|
Item 5.
|
Market for the Registrant’s Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities.
|
|
|
Item 6.
|
Selected Financial Data.
|
|
|
Item 7.
|
Management’s Discussion and Analysis of Financial Condition and Results of Operations.
|
|
|
Item 7A.
|
Quantitative and Qualitative Disclosures About Market Risk.
|
|
|
Item 8.
|
Financial Statements and Supplementary Data.
|
|
|
Item 9.
|
Changes in and Disagreements with Accountants on Accounting and Financial Disclosure.
|
|
|
Item 9A.
|
Controls and Procedures.
|
|
|
Item 9B.
|
Other Information.
|
|
|
|
|
|
|
PART III
|
||
|
|
|
|
|
Item 10.
|
Directors, Executive Officers and Corporate Governance.
|
|
|
Item 11.
|
Executive Compensation.
|
|
|
Item 12.
|
Security Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters.
|
|
|
Item 13.
|
Certain Relationships and Related Transactions, and Director Independence.
|
|
|
Item 14.
|
Principal Accountant Fees and Services.
|
|
|
|
|
|
|
PART IV
|
||
|
|
|
|
|
Item 15.
|
Exhibits and Financial Statement Schedules.
|
|
|
Fuel
|
CO
2
emissions, lbs/million Btu
|
|
Natural Gas
|
116.7
|
|
Distillate Oil
|
160.9
|
|
Coal
|
206.7
|
|
(1)
|
Average U.S. Powerplant CO2 emission rate of 1,293 (lb/MWh) from USEPA eGrid 2010.
|
|
(2)
|
Coal Combined Cycle emissions based upon 50% efficiency (assumed to be the same as Natural Gas) and coal CO2 emission rate from EPA website.
|
|
(3)
|
“Best in Class” Natural Gas combined cycle plant emissions based upon 50% efficiency. (Northwest Power Planning Council “Natural Gas Combined-cycle Gas Turbine Power Plants, August 2002).
|
|
(4)
|
Fuel Cell and Microturbine emissions based upon data listed in the ICF International Combined Heat and Power Market Assessment, April 2010.
|
|
(1)
|
Based upon an annual output of 100 kW and 670,000 Btu/hr of hot water.
|
|
(2)
|
Average U.S. powerplant NOx emission rate of 1.7717 lb/MWh from (USEPA eGrid 2010), CO data not available.
|
|
(3)
|
Gas boiler efficiency of 78% (www.eia.gov) with emissions of 20 ppm NOx @ 3% O2 (California Regulation SCAQMD Rule 1146.2) and 50 ppmvCO @ 3% O2 (California Regulation SCAQMD BACT).
|
|
(1)
|
Tecogen emissions based upon actual third party source test data.
|
|
(2)
|
Microturbine and Fuel Cell NOx data from California Energy Commission, Combined Heat and Power Market Assessment 2010, by ICF international.
|
|
(3)
|
Stationary engine BACT as defined by SCAQMD.
|
|
(4)
|
Limits represent CARB 2007 emission standard for Distributed Generation with a 60% (HHV) Overall Efficiency credit.
|
|
(5)
|
CO data not available for microturbine and fuel cell.
|
|
|
2014
|
|
2013
|
||||
|
Products:
|
|
|
|
|
|
||
|
Cogeneration
|
$
|
5,364,810
|
|
|
$
|
5,199,649
|
|
|
Chiller
|
3,260,224
|
|
|
1,146,401
|
|
||
|
Total product revenue
|
8,625,034
|
|
|
6,346,050
|
|
||
|
Services
|
7,438,125
|
|
|
7,071,388
|
|
||
|
Installations
|
3,279,505
|
|
|
2,432,431
|
|
||
|
Total service revenue
|
10,717,630
|
|
|
9,503,819
|
|
||
|
Total revenue
|
$
|
19,342,664
|
|
|
$
|
15,849,869
|
|
|
•
|
The
InVerde
®
and TECOGEN
®
cogeneration units;
|
|
•
|
TECOCHILL
®
chillers;
|
|
•
|
Ilios high-efficiency water heaters; and
|
|
•
|
Ultra
low-emissions technology.
|
|
1.
|
Third-party laboratory verification.
The AVL California Technology Center, a long-standing research and technology partner with the international automotive industry, confirmed our results in their state-of-the-art dynamometer test cell, which was outfitted with sophisticated emissions measurement equipment.
|
|
2.
|
Verifying longevity and reliability in the field.
We did so by equipping one of our TECOGEN 75-kW units, already operating at a customer location in Southern California, with the Ultra low-emissions technology and a device to monitor emissions continuously. To date, the Ultra low-emissions system has operated successfully for more than 25,000 hours (approximately 3 1/2 years) and has consistently complied with California’s emission standards. This field test is ongoing.
|
|
3.
|
Additional independent tests.
During the field test, two companies licensed in California to test emissions each verified our results at different times. The results from one of these tests (obtained in August 2011) enabled us to qualify for New Jersey’s fast-track permitting. Virtually every state nationwide requires some kind of permit related to local air quality, but New Jersey allows an exemption for systems such as ours that demonstrate superior emissions performance. This certification was granted in November 2011, and since then we have sold Ultra low-emissions systems to several customers.
|
|
•
|
Sacramento Municipal Utility District — has provided test sites for the Company since 2010.
|
|
•
|
Southern California Gas Company and San Diego Gas & Electric Company, each a Sempra Energy subsidiary — have granted us research and development contracts since 2004.
|
|
•
|
Lawrence Berkeley National Laboratory — research and development contracts since 2005.
|
|
•
|
Consortium for Electric Reliability Technology Solutions — research and development contracts and provided a test site to the Company since 2005.
|
|
•
|
California Energy Commission — research and development contracts from 2004 until March 2013.
|
|
•
|
The AVL California Technology Center — support role in performance of research and development contracts as well as internal research and development on our emission control system from August 2009 to November 2011.
|
|
•
|
8,578,704: “Assembly and method for reducing nitrogen oxides, carbon monoxide, and hydrocarbons in exhausts of internal combustion engines.” This patent, granted in November 2013, is for the
Ultra
emission system applicable to all our products.
|
|
•
|
7,239,034: “Engine driven power inverter system with cogeneration”. This patent, granted in July 2007, pertains to the utilization of an engine-driven CHP module combined with an inverter and applies to our
InVerde
product specifically.
|
|
•
|
7,243,017: “Method for controlling internal combustion engine emissions”. This patent, granted in July 2007, applies to the specific algorithms used in our engine controller for metering the fuel usage to obtain the correct combustion mixture. It applies to most of our engines.
|
|
•
|
Product safety certifications and interconnection requirements;
|
|
•
|
Air pollution regulations, which govern the emissions allowed in engine exhaust;
|
|
•
|
State and federal incentives for CHP technology; and
|
|
•
|
Electric utility pricing and related regulations.
|
|
•
|
results and timing of our product development;
|
|
•
|
results of the development of our competitors’ products;
|
|
•
|
regulatory actions with respect to our products or our competitors’ products;
|
|
•
|
actual or anticipated fluctuations in our financial condition and operating results;
|
|
•
|
actual or anticipated changes in our growth rate relative to our competitors;
|
|
•
|
actual or anticipated fluctuations in our competitors’ operating results or changes in their growth rate;
|
|
•
|
competition from existing products or new products that may emerge;
|
|
•
|
announcements by us or our competitors of significant acquisitions, strategic partnerships, joint ventures, collaborations, or capital commitments;
|
|
•
|
issuance of new or updated research or reports by securities analysts;
|
|
•
|
fluctuations in the valuation of companies perceived by investors to be comparable to us;
|
|
•
|
share price and volume fluctuations attributable to inconsistent trading volume levels of our shares;
|
|
•
|
additions or departures of key management or personnel;
|
|
•
|
disputes or other developments related to proprietary rights, including patents, litigation matters, and our ability to obtain, maintain, defend or enforce proprietary rights relating to our products and technologies;
|
|
•
|
announcement or expectation of additional financing efforts;
|
|
•
|
sales of our Common Stock by us, our insiders, or our other stockholders; and
|
|
•
|
general economic and market conditions.
|
|
•
|
have an auditor report on our internal controls over financial reporting pursuant to Section 404(b) of the Sarbanes-Oxley Act;
|
|
•
|
comply with any requirement that may be adopted by the Public Company Accounting Oversight Board regarding mandatory audit firm rotation or a supplement to the auditor’s report providing additional information about the audit and the financial statements (i.e., an auditor discussion and analysis);
|
|
•
|
submit certain executive compensation matters to shareholder non-binding advisory votes;
|
|
•
|
submit for shareholder approval golden parachute payments not previously approved; and
|
|
•
|
disclose certain executive compensation related items such as the correlation between executive compensation and financial performance and comparisons of the Chief Executive Officer’s compensation to median employee compensation, when such disclosure requirements are adopted.
|
|
Item 5.
|
Market for Registrant’s Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities.
|
|
Year Ended December 31, 2014
|
|
High
|
|
Low
|
|
2nd Quarter
|
|
$31.31
|
|
$5.06
|
|
3rd Quarter
|
|
$8.18
|
|
$4.97
|
|
4th Quarter
|
|
$7.80
|
|
$4.59
|
|
|
Number of securities to be issued upon exercise of outstanding options, warrants and rights
|
Weighted-average exercise price of outstanding options, warrants and rights
|
Number of securities remaining available for future issuance under equity compensation plans (excluding securities reflected in column (a))
|
|
Plan Category
|
(a)
|
(b)
|
(c)
|
|
Equity compensation plans approved by security holders
(1)
|
1,356,325
|
$2.77
|
1,748,783
|
|
Equity compensation plans not approved by security holders
|
—
|
—
|
—
|
|
Total
|
1,356,325
|
$2.77
|
1,748,783
|
|
|
Years ended December 31,
|
||||
|
|
2014
|
|
2013
|
||
|
Revenues
|
100.0
|
%
|
|
100.0
|
%
|
|
Cost of Sales
|
66.9
|
|
|
68.3
|
|
|
Gross Profit
|
33.1
|
|
|
31.7
|
|
|
General and administrative
|
37.6
|
|
|
37.4
|
|
|
Selling
|
9.3
|
|
|
9.0
|
|
|
Research and development
|
5.4
|
|
|
6.9
|
|
|
Aborted public offering costs
|
—
|
|
|
1.6
|
|
|
Loss from operations
|
(19.2
|
)
|
|
(23.2
|
)
|
|
Total other expense, net
|
(0.9
|
)
|
|
(0.9
|
)
|
|
Consolidated net loss
|
(20.1
|
)
|
|
(24.1
|
)
|
|
Less: Loss attributable to the noncontrolling interest
|
0.6
|
|
|
2.3
|
|
|
Net loss attributable to Tecogen Inc.
|
(19.5
|
)
|
|
(21.8
|
)
|
|
(i)
|
Disagreements with McGladrey on any matter of accounting principles or practices, financial statement disclosure or auditing scope or procedure, which disagreements, if not resolved to the satisfaction of McGladrey, would have caused them to make reference to the subject matter of the disagreement(s) in connection with its reports on the financial statements for such years; or
|
|
(ii)
|
“Reportable events,” as that term is described in Item 304(a)(1)(v) of Regulation S-K.
|
|
(a)
|
REPORTS OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRMS
|
|
(b)
|
Exhibits
|
|
|
TECOGEN INC.
|
|
|
|
(Registrant)
|
|
|
|
|
|
|
|
By:
|
/s/ John N. Hatsopoulos
|
|
|
Co-Chief Executive Officer
|
|
|
|
(Principal Executive Officer)
|
|
|
|
|
|
|
|
By:
|
/s/ Benjamin Locke
|
|
|
Co-Chief Executive Officer
|
|
|
|
(Principal Executive Officer)
|
|
|
|
|
|
|
|
By:
|
/s/ David A. Garrison
|
|
|
Chief Financial Officer, Treasurer and Secretary
|
|
|
|
(Principal Financial and Accounting Officer)
|
|
|
Signature
|
|
Title
|
|
Date
|
|
|
|
|
|
|
|
/s/ Angelina M. Galiteva
|
|
Chairman of the Board
|
|
March 24, 2015
|
|
Angelina M. Galiteva
|
|
|
|
|
|
|
|
|
|
|
|
/s/ John N. Hatsopoulos
|
|
Director and Co-Chief Executive Officer
|
|
March 24, 2015
|
|
John N. Hatsopoulos
|
|
(Principal Executive Officer)
|
|
|
|
|
|
|
|
|
|
/s/ Benjamin Locke
|
|
Co-Chief Executive Officer
|
|
March 24, 2015
|
|
Benjamin Locke
|
|
(Principal Executive Officer)
|
|
|
|
|
|
|
|
|
|
/s/ David A. Garrison
|
|
Chief Financial Officer, Treasurer and Secretary
|
|
March 24, 2015
|
|
David A. Garrison
|
|
(Principal Financial and Accounting Officer)
|
|
|
|
|
|
|
|
|
|
/s/ Charles T. Maxwell
|
|
Director
|
|
March 24, 2015
|
|
Charles T. Maxwell
|
|
|
|
|
|
|
|
|
|
|
|
/s/ Ahmed F. Ghoniem
|
|
Director
|
|
March 24, 2015
|
|
Ahmed F. Ghoniem
|
|
|
|
|
|
|
|
|
|
|
|
/s/ Joseph E. Aoun
|
|
Director
|
|
March 24, 2015
|
|
Joseph E. Aoun
|
|
|
|
|
|
|
|
|
|
|
|
/s/ Earl R. Lewis
|
|
Director
|
|
March 24, 2015
|
|
Earl R. Lewis
|
|
|
|
|
|
Exhibit Number
|
Description
|
|
|
3.1
b
|
Amended and Restated Certificate of Incorporation.
|
|
|
3.2
b
|
Amended and Restated Bylaws.
|
|
|
4.1
b
|
Specimen Common Stock Certificate of Tecogen Inc.
|
|
|
4.2
a
|
Form of Restricted Stock Purchase Agreement.
|
|
|
4.3+
b
|
Form of Stock Option Agreement.
|
|
|
4.4+
a
|
Indenture and Form of 6% Convertible Debenture Due 2004, dated September 24, 2001.
|
|
|
10.2
a
|
Form of Tecogen Inc. Subscription Agreement for private placement of Common Stock.
|
|
|
10.3#
b
|
Facilities and Support Services Agreement between American DG Energy Inc. and Tecogen Inc., dated July 1, 2012.
|
|
|
10.4
b
|
First Amendment to the Facilities, Support Services, and Business Agreement between American DG Energy Inc. and Tecogen Inc., dated July 1, 2013.
|
|
|
10.5
b
|
Second Amendment to the Facilities, Support Services, and Business Agreement between American DG Energy Inc. and Tecogen Inc., dated November 12, 2013.
|
|
|
10.6#
b
|
General Motors LLC, Customer Care and Aftersales Agreement, dated November 15, 2011.
|
|
|
10.7
b
|
Lease Agreement between Atlantic-Waltham Investment II, LLC, and Tecogen Inc., dated May 14, 2008.
|
|
|
10.8
b
|
Second Amendment to Lease Agreement between Atlantic-Waltham Investment II, LLC, and Tecogen Inc., dated January 16, 2013.
|
|
|
10.9
a
|
Form of Demand Promissory Note Agreement by Tecogen Inc. in favor of John N. Hatsopoulos.
|
|
|
10.10
|
Demand Promissory Note by Tecogen Inc., dated October 3, 2013, in favor of John N. Hatsopoulos (incorporated by reference to the registrant’s Quarterly Report on Form 10-Q, for the quarter ended September 30, 2013).
|
|
|
10.11
a
|
Form of Sales Representative Agreement.
|
|
|
10.12#
b
|
Asset Purchase Agreement with Danotek, LLC.
|
|
|
10.13#
b
|
Exclusive License Agreement between Tecogen Inc. and the Wisconsin Alumni Research Foundation, dated February 5, 2007.
|
|
|
10.14
a
|
Grant Award Number PIR-08-022, dated July 2, 2009.
|
|
|
10.15#
b
|
Sales Representative Agreement between American DG Energy Inc. and Ilios Dynamics, dated October 20, 2009.
|
|
|
10.16
b
|
First Amendment to the Sales Representative Agreement, dated November 12, 2013, between Ilios Inc. and American DG Energy Inc.
|
|
|
10.17
|
Revolving Line of Credit Agreement, dated March 25, 2013, between Tecogen Inc. and John N. Hatsopoulos (incorporated by reference to the registrant’s Current Report on Form 8-K, dated March 25, 2013).
|
|
|
10.18
b
|
First Amendment to the Revolving Line of Credit Agreement, dated August 13, 2013, between Tecogen Inc. and John N. Hatsopoulos.
|
|
|
10.19
b
|
Form of Common Stock Purchase Agreement.
|
|
|
10.20
b
|
Form of Common Stock Purchase Agreement.
|
|
|
10.21
b
|
Senior Convertible Promissory Note, dated December 23, 2013, by Tecogen Inc. in favor of Michaelson Capital Special Finance Fund LP.
|
|
|
10.22
b
|
Collective Bargaining Agreement, dated February 25, 2014, between Tecogen Inc. and International Union of Operating Engineers, Local 68, 68A, 68B.
|
|
|
10.23
b
|
Revolving Line of Credit Agreement between Tecogen Inc. and John N. Hatsopoulos, dated March 26, 2014.
|
|
|
10.24*+
|
Tecogen Inc. 2006 Stock Incentive Plan, as amended on January 24, 2014 with stockholder approval on July 15, 2014.
|
|
|
14.1
a
|
Code of Business Conduct and Ethics
|
|
|
21.1
b
|
List of subsidiaries
|
|
|
23.1*
|
Consent of Wolf & Company, P.C.
|
|
|
23.2*
|
Consent of McGladrey LLP.
|
|
|
31.1*
|
Rule 13a-14(a) Certification of Co-Chief Executive Officer
|
|
|
31.2*
|
Rule 13a-14(a) Certification of Co-Chief Executive Officer
|
|
|
Exhibit Number
|
Description
|
|
|
31.3*
|
Rule 13a-14(a) Certification of Chief Financial Officer
|
|
|
32.1*
|
Section 1350 Certifications of Co-Chief Executive Officers and Chief Financial Officer
|
|
|
101.INS*
|
XBRL Instance Document
|
|
|
101.SCH*
|
XBRL Taxonomy Extension Schema
|
|
|
101.CAL*
|
XBRL Taxonomy Extension Calculation Linkbase
|
|
|
101.DEF*
|
XBRL Taxonomy Extension Definition Linkbase
|
|
|
101.LAB*
|
XBRL Taxonomy Extension Label Linkbase
|
|
|
101.PRE*
|
XBRL Taxonomy Extension Presentation Linkbase
|
|
|
|
|
|
|
*
|
Filed herewith.
|
|
|
|
|
|
|
#
|
Confidential Treatment has been granted for portions of this document. The confidential portions were omitted and filed separately, on a confidential basis, with the Securities and Exchange Commission.
|
|
|
+
|
Management contract or compensatory plan or agreement.
|
|
|
a
|
Incorporated by reference to the registrant’s Registration Statement on Form S-1, as amended, originally filed with the SEC on December 22, 2011 (Registration No. 333-178697)
|
|
|
b
|
Incorporated by reference to the registrant's Registration Statement on Form S-1, as amended filed with the SEC on June 27, 2014 (Registration No. 333-193791)
|
|
|
|
2014
|
|
2013
|
||||
|
ASSETS
|
|
|
|
|
|
||
|
Current assets:
|
|
|
|
|
|
||
|
Cash and cash equivalents
|
$
|
1,186,033
|
|
|
$
|
7,713,899
|
|
|
Short-term investments, restricted
|
585,702
|
|
|
—
|
|
||
|
Accounts receivable, net
|
4,750,437
|
|
|
3,740,885
|
|
||
|
Unbilled revenue
|
696,912
|
|
|
646,398
|
|
||
|
Inventory, net
|
4,090,221
|
|
|
3,343,793
|
|
||
|
Due from related party
|
600,251
|
|
|
—
|
|
||
|
Deferred financing costs
|
50,201
|
|
|
140,433
|
|
||
|
Prepaid and other current assets
|
348,868
|
|
|
340,013
|
|
||
|
Total current assets
|
12,308,625
|
|
|
15,925,421
|
|
||
|
|
|
|
|
||||
|
Property, plant and equipment, net
|
658,421
|
|
|
638,026
|
|
||
|
Deferred financing costs, net of current portion
|
48,990
|
|
|
—
|
|
||
|
Intangible assets, net
|
1,011,300
|
|
|
953,327
|
|
||
|
Goodwill
|
40,870
|
|
|
40,870
|
|
||
|
Other assets
|
53,325
|
|
|
72,425
|
|
||
|
TOTAL ASSETS
|
$
|
14,121,531
|
|
|
$
|
17,630,069
|
|
|
|
|
|
|
||||
|
LIABILITIES AND STOCKHOLDERS’ EQUITY
|
|
|
|
|
|
||
|
Current liabilities:
|
|
|
|
|
|
||
|
Demand notes payable and line of credit, related party
|
$
|
—
|
|
|
$
|
2,950,000
|
|
|
Senior convertible promissory note, related party
|
—
|
|
|
3,000,000
|
|
||
|
Accounts payable
|
2,416,313
|
|
|
2,338,046
|
|
||
|
Accrued expenses
|
1,008,153
|
|
|
1,139,554
|
|
||
|
Deferred revenue
|
1,666,576
|
|
|
613,915
|
|
||
|
Due to related party
|
—
|
|
|
119,667
|
|
||
|
Interest payable, related party
|
—
|
|
|
198,450
|
|
||
|
Total current liabilities
|
5,091,042
|
|
|
10,359,632
|
|
||
|
|
|
|
|
||||
|
Long-term liabilities:
|
|
|
|
|
|
||
|
Deferred revenue, net of current portion
|
207,153
|
|
|
204,544
|
|
||
|
Senior convertible promissory note, related party
|
3,000,000
|
|
|
—
|
|
||
|
Total liabilities
|
8,298,195
|
|
|
10,564,176
|
|
||
|
|
|
|
|
||||
|
Commitments and contingencies (Note 8)
|
—
|
|
|
—
|
|
||
|
|
|
|
|
||||
|
Stockholders’ equity:
|
|
|
|
|
|
||
|
Tecogen Inc. stockholders’ equity:
|
|
|
|
|
|
||
|
Common stock, $0.001 par value; 100,000,000 shares authorized; 15,905,881 and 15,155,200 issued and outstanding at December 31, 2014 and 2013, respectively
|
15,906
|
|
|
15,155
|
|
||
|
Additional paid-in capital
|
25,088,213
|
|
|
22,463,996
|
|
||
|
Accumulated deficit
|
(18,955,023
|
)
|
|
(15,209,212
|
)
|
||
|
Total Tecogen Inc. stockholders’ equity
|
6,149,096
|
|
|
7,269,939
|
|
||
|
Noncontrolling interest
|
(325,760
|
)
|
|
(204,046
|
)
|
||
|
Total stockholders’ equity
|
5,823,336
|
|
|
7,065,893
|
|
||
|
|
|
|
|
||||
|
TOTAL LIABILITIES AND STOCKHOLDERS’ EQUITY
|
$
|
14,121,531
|
|
|
$
|
17,630,069
|
|
|
|
2014
|
|
2013
|
||||
|
Revenues
|
|
|
|
|
|
||
|
Products
|
$
|
8,625,034
|
|
|
$
|
6,346,050
|
|
|
Services
|
10,717,630
|
|
|
9,503,819
|
|
||
|
Total revenues
|
19,342,664
|
|
|
15,849,869
|
|
||
|
|
|
|
|
||||
|
Cost of sales
|
|
|
|
|
|
||
|
Products
|
6,347,583
|
|
|
4,709,767
|
|
||
|
Services
|
6,596,017
|
|
|
6,109,974
|
|
||
|
Total cost of sales
|
12,943,600
|
|
|
10,819,741
|
|
||
|
|
|
|
|
||||
|
Gross profit
|
6,399,064
|
|
|
5,030,128
|
|
||
|
|
|
|
|
||||
|
Operating expenses
|
|
|
|
|
|
||
|
General and administrative
|
7,264,630
|
|
|
5,931,144
|
|
||
|
Selling
|
1,796,268
|
|
|
1,423,587
|
|
||
|
Research and development
|
1,041,483
|
|
|
1,086,989
|
|
||
|
Aborted public offering costs
|
—
|
|
|
258,512
|
|
||
|
Total operating expenses
|
10,102,381
|
|
|
8,700,232
|
|
||
|
|
|
|
|
||||
|
Loss from operations
|
(3,703,317
|
)
|
|
(3,670,104
|
)
|
||
|
|
|
|
|
||||
|
Other income (expense)
|
|
|
|
|
|
||
|
Interest and other income
|
9,710
|
|
|
3,958
|
|
||
|
Interest expense
|
(177,345
|
)
|
|
(141,065
|
)
|
||
|
Total other expense, net
|
(167,635
|
)
|
|
(137,107
|
)
|
||
|
|
|
|
|
||||
|
Loss before income taxes
|
(3,870,952
|
)
|
|
(3,807,211
|
)
|
||
|
Consolidated net loss
|
(3,870,952
|
)
|
|
(3,807,211
|
)
|
||
|
|
|
|
|
||||
|
Less: Loss attributable to the noncontrolling interest
|
125,140
|
|
|
357,722
|
|
||
|
Net loss attributable to Tecogen Inc.
|
$
|
(3,745,812
|
)
|
|
$
|
(3,449,489
|
)
|
|
|
|
|
|
||||
|
Net loss per share - basic and diluted
|
$
|
(0.24
|
)
|
|
$
|
(0.26
|
)
|
|
|
|
|
|
||||
|
Weighted average shares outstanding - basic and diluted
|
15,607,897
|
|
|
13,385,155
|
|
||
|
|
|
Tecogen Inc.
|
|
|
|
|
|||||||||||||||||
|
|
|
Common Stock Shares
|
|
Common
Stock
$.001
Par Value
|
|
Additional
Paid-In
Capital
|
|
Accumulated
Deficit
|
Noncontrolling
Interest
|
Total
|
|||||||||||||
|
Balance at December 31, 2012
|
|
13,611,974
|
|
|
$
|
13,612
|
|
|
$
|
16,360,821
|
|
|
$
|
(11,759,723
|
)
|
|
$
|
168,325
|
|
|
$
|
4,783,035
|
|
|
Sale of common stock
|
|
1,476,789
|
|
|
1,477
|
|
|
5,965,328
|
|
|
—
|
|
|
—
|
|
|
5,966,805
|
|
|||||
|
Conversion of related party convertible notes to common stock
|
|
75,806
|
|
|
76
|
|
|
90,891
|
|
|
—
|
|
|
—
|
|
|
90,967
|
|
|||||
|
Conversion of accrued interest on related party convertible notes to common stock
|
|
3,131
|
|
|
3
|
|
|
11,277
|
|
|
—
|
|
|
—
|
|
|
11,280
|
|
|||||
|
Exercise of stock options
|
|
25,000
|
|
|
25
|
|
|
2,975
|
|
|
—
|
|
|
—
|
|
|
3,000
|
|
|||||
|
Forfeitures of restricted stock grant
|
|
(37,500
|
)
|
|
(38
|
)
|
|
(112
|
)
|
|
—
|
|
|
(200
|
)
|
|
(350
|
)
|
|||||
|
Stock based compensation expense
|
|
—
|
|
|
—
|
|
|
32,816
|
|
|
—
|
|
|
(14,449
|
)
|
|
18,367
|
|
|||||
|
Net loss
|
|
—
|
|
|
—
|
|
|
—
|
|
|
(3,449,489
|
)
|
|
(357,722
|
)
|
|
(3,807,211
|
)
|
|||||
|
Balance at December 31, 2013
|
|
15,155,200
|
|
|
$
|
15,155
|
|
|
$
|
22,463,996
|
|
|
$
|
(15,209,212
|
)
|
|
$
|
(204,046
|
)
|
|
$
|
7,065,893
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||
|
Sale of common stock
|
|
649,106
|
|
|
649
|
|
|
2,339,545
|
|
|
—
|
|
|
—
|
|
|
2,340,194
|
|
|||||
|
Exercise of stock options
|
|
101,575
|
|
|
102
|
|
|
161,163
|
|
|
—
|
|
|
—
|
|
|
161,265
|
|
|||||
|
Stock based compensation expense
|
|
—
|
|
|
—
|
|
|
123,510
|
|
|
—
|
|
|
3,426
|
|
|
126,936
|
|
|||||
|
Net loss
|
|
—
|
|
|
—
|
|
|
—
|
|
|
(3,745,812
|
)
|
|
(125,140
|
)
|
|
(3,870,952
|
)
|
|||||
|
Balance at December 31, 2014
|
|
15,905,881
|
|
|
$
|
15,906
|
|
|
$
|
25,088,214
|
|
|
$
|
(18,955,024
|
)
|
|
$
|
(325,760
|
)
|
|
$
|
5,823,336
|
|
|
CASH FLOWS FROM OPERATING ACTIVITIES:
|
2014
|
|
2013
|
||||
|
|
|
|
|
|
|||
|
Net loss
|
$
|
(3,870,952
|
)
|
|
$
|
(3,807,211
|
)
|
|
Adjustments to reconcile net loss to net cash provided by (used in) operating activities:
|
|
|
|
|
|
||
|
Depreciation and amortization
|
278,865
|
|
|
256,459
|
|
||
|
Loss on Disposal of Asset
|
1,209
|
|
|
—
|
|
||
|
Provision for losses on accounts receivable
|
53,800
|
|
|
50,600
|
|
||
|
Provision (recovery) for inventory reserve
|
—
|
|
|
(32,000
|
)
|
||
|
Stock-based compensation
|
126,936
|
|
|
18,367
|
|
||
|
Non-cash interest expense
|
50,910
|
|
|
—
|
|
||
|
Changes in operating assets (increase) decrease in:
|
|
|
|
|
|
||
|
Short-term investments, restricted
|
(1,303
|
)
|
|
(202
|
)
|
||
|
Accounts receivable
|
(1,063,352
|
)
|
|
(1,091,242
|
)
|
||
|
Inventory
|
(746,428
|
)
|
|
62,229
|
|
||
|
Unbilled revenue
|
(50,514
|
)
|
|
(646,398
|
)
|
||
|
Due from related party
|
(600,251
|
)
|
|
55,837
|
|
||
|
Prepaid expenses and other current assets
|
(8,855
|
)
|
|
62,833
|
|
||
|
Other assets
|
19,100
|
|
|
(33,000
|
)
|
||
|
Changes in operating liabilities increase (decrease) in:
|
|
|
|
|
|
||
|
Accounts payable
|
78,267
|
|
|
1,187,036
|
|
||
|
Accrued expenses
|
(131,401
|
)
|
|
331,632
|
|
||
|
Deferred revenue
|
1,055,270
|
|
|
(2,186
|
)
|
||
|
Interest payable, related party
|
(198,450
|
)
|
|
83,560
|
|
||
|
Due to related party
|
(119,667
|
)
|
|
119,667
|
|
||
|
Net cash used in operating activities
|
(5,126,816
|
)
|
|
(3,384,019
|
)
|
||
|
CASH FLOWS FROM INVESTING ACTIVITIES:
|
|
|
|
|
|
||
|
Purchases of property and equipment
|
(223,574
|
)
|
|
(202,700
|
)
|
||
|
Disposal of property and equipment
|
7,092
|
|
|
—
|
|
||
|
Purchases of intangible assets
|
(141,959
|
)
|
|
(397,950
|
)
|
||
|
Cash paid for asset acquisition
|
—
|
|
|
(497,800
|
)
|
||
|
Purchases of short-term investments
|
(584,400
|
)
|
|
—
|
|
||
|
Maturities of short-term investments
|
—
|
|
|
182,061
|
|
||
|
Net cash used in investing activities
|
(942,841
|
)
|
|
(916,389
|
)
|
||
|
CASH FLOWS FROM FINANCING ACTIVITIES:
|
|
|
|
|
|
||
|
Payments made on demand notes payable, related party
|
(2,950,000
|
)
|
|
(37,500
|
)
|
||
|
Proceeds from issuance of demand notes payable and line of credit, related party
|
—
|
|
|
1,650,000
|
|
||
|
Proceeds from sale of common stock, net of costs
|
2,340,194
|
|
|
5,966,805
|
|
||
|
Proceeds from exercise of stock options
|
161,265
|
|
|
3,000
|
|
||
|
Proceeds from issuance of senior convertible promissory note
|
—
|
|
|
3,000,000
|
|
||
|
Payments for debt issuance costs
|
(9,668
|
)
|
|
(140,433
|
)
|
||
|
Purchase of restricted stock
|
—
|
|
|
(350
|
)
|
||
|
Net cash (used in) provided by financing activities
|
(458,209
|
)
|
|
10,441,522
|
|
||
|
Net increase (decrease) in cash and cash equivalents
|
(6,527,866
|
)
|
|
6,141,114
|
|
||
|
Cash and cash equivalents, beginning of the year
|
7,713,899
|
|
|
1,572,785
|
|
||
|
Cash and cash equivalents, end of the year
|
$
|
1,186,033
|
|
|
$
|
7,713,899
|
|
|
Cash paid for interest
|
$
|
324,885
|
|
|
$
|
55,639
|
|
|
Non-cash investing and financing activities:
|
|
|
|
|
|
||
|
Conversion of accrued convertible debenture interest into common stock
|
$
|
—
|
|
|
$
|
11,280
|
|
|
Conversion of related party notes to common stock
|
—
|
|
|
90,967
|
|
||
|
Settlement of shareholder receivable
|
$
|
—
|
|
|
$
|
—
|
|
|
Cash paid for asset acquisition:
|
|
|
|
||||
|
Inventory
|
$
|
—
|
|
|
$
|
17,400
|
|
|
Property and equipment
|
—
|
|
|
199,530
|
|
||
|
Intangible assets
|
—
|
|
|
240,000
|
|
||
|
Goodwill
|
—
|
|
|
40,870
|
|
||
|
|
2014
|
|
2013
|
||||
|
Products:
|
|
|
|
|
|
||
|
Cogeneration
|
$
|
5,364,810
|
|
|
$
|
5,199,649
|
|
|
Chiller
|
3,260,224
|
|
|
1,146,401
|
|
||
|
Total Product Revenue
|
8,625,034
|
|
|
6,346,050
|
|
||
|
Services:
|
|
|
|
||||
|
Service contracts
|
7,438,125
|
|
|
7,071,388
|
|
||
|
Installations
|
3,279,505
|
|
|
2,432,431
|
|
||
|
Total Service Revenue
|
10,717,630
|
|
|
9,503,819
|
|
||
|
Total Revenue
|
$
|
19,342,664
|
|
|
$
|
15,849,869
|
|
|
|
2014
|
|
2013
|
||||
|
Loss available to stockholders
|
$
|
(3,745,812
|
)
|
|
$
|
(3,449,489
|
)
|
|
Weighted average shares outstanding - Basic and diluted
|
15,607,897
|
|
|
13,385,155
|
|
||
|
Basic and diluted loss per share
|
$
|
(0.24
|
)
|
|
$
|
(0.26
|
)
|
|
|
|
|
|
||||
|
Anti-dilutive shares underlying stock options outstanding
|
1,356,325
|
|
|
1,148,000
|
|
||
|
Anti-dilutive convertible debentures
|
555,556
|
|
|
555,556
|
|
||
|
|
2014
|
|
2013
|
||||
|
Gross raw materials
|
$
|
4,348,786
|
|
|
$
|
3,539,732
|
|
|
Less - reserves
|
(300,000
|
)
|
|
(300,000
|
)
|
||
|
Net raw materials
|
4,048,786
|
|
|
3,239,732
|
|
||
|
Work-in-process
|
22,250
|
|
|
104,061
|
|
||
|
Finished goods
|
19,185
|
|
|
—
|
|
||
|
|
$
|
4,090,221
|
|
|
$
|
3,343,793
|
|
|
|
Product
Certifications
|
|
Patents
|
|
Developed Technology
|
|
Total
|
||||||||
|
Balance at December 31, 2014
|
|
|
|
|
|
|
|
|
|
|
|||||
|
Intangible assets
|
$
|
475,344
|
|
|
$
|
514,930
|
|
|
240,000
|
|
|
$
|
1,230,274
|
|
|
|
Less - accumulated amortization
|
(128,732
|
)
|
|
(62,242
|
)
|
|
(28,000
|
)
|
|
(218,974
|
)
|
||||
|
|
$
|
346,612
|
|
|
$
|
452,688
|
|
|
$
|
212,000
|
|
|
$
|
1,011,300
|
|
|
|
|
|
|
|
|
|
|
||||||||
|
Balance at December 31, 2013
|
|
|
|
|
|
|
|
|
|
|
|||||
|
Intangible assets
|
$
|
406,706
|
|
|
$
|
441,609
|
|
|
240,000
|
|
|
$
|
1,088,315
|
|
|
|
Less - accumulated amortization
|
(83,405
|
)
|
|
(39,583
|
)
|
|
(12,000
|
)
|
|
(134,988
|
)
|
||||
|
|
$
|
323,301
|
|
|
$
|
402,026
|
|
|
$
|
228,000
|
|
|
$
|
953,327
|
|
|
2015
|
$
|
92,389
|
|
|
2016
|
137,096
|
|
|
|
2017
|
137,096
|
|
|
|
2018
|
130,899
|
|
|
|
2019
|
114,248
|
|
|
|
Thereafter
|
399,572
|
|
|
|
|
$
|
1,011,300
|
|
|
|
Estimated Useful
Life (in Years)
|
|
2014
|
|
2013
|
||||
|
Machinery and equipment
|
5 - 7 years
|
|
$
|
936,705
|
|
|
$
|
773,894
|
|
|
Furniture and fixtures
|
5 years
|
|
99,346
|
|
|
79,612
|
|
||
|
Computer software
|
3 - 5 years
|
|
67,215
|
|
|
67,215
|
|
||
|
Leasehold improvements
|
*
|
|
427,791
|
|
|
397,158
|
|
||
|
|
|
|
1,531,057
|
|
|
1,317,879
|
|
||
|
Less - accumulated depreciation and amortization
|
|
|
(872,636
|
)
|
|
(679,853
|
)
|
||
|
Net property, plant and equipment
|
|
|
$
|
658,421
|
|
|
$
|
638,026
|
|
|
Years Ending December 31,
|
|
Amount
|
||
|
2015
|
|
$
|
574,108
|
|
|
2016
|
|
524,159
|
|
|
|
2017
|
|
519,399
|
|
|
|
2018
|
|
500,272
|
|
|
|
2019
|
|
506,432
|
|
|
|
2020 and thereafter
|
|
2,235,785
|
|
|
|
Total
|
|
$
|
4,860,155
|
|
|
Warranty reserve, December 31, 2012
|
$
|
90,200
|
|
|
Warranty provision for units sold
|
179,841
|
|
|
|
Costs of warranty incurred
|
(175,041
|
)
|
|
|
Warranty reserve, December 31, 2013
|
95,000
|
|
|
|
Warranty provision for units sold
|
207,583
|
|
|
|
Costs of warranty incurred
|
(155,583
|
)
|
|
|
Warranty reserve, December 31, 2014
|
$
|
147,000
|
|
|
Common Stock Options
|
Number of
Options
|
|
Exercise
Price Per
Share
|
|
Weighted
Average Exercise
Price
|
|
Weighted
Average Remaining
Life
|
|
Aggregate
Intrinsic
Value
|
||||||
|
Outstanding, December 31, 2013
|
1,148,000
|
|
|
$1.20-$4.50
|
|
|
$
|
2.13
|
|
|
5.80 years
|
|
$
|
2,721,100
|
|
|
Granted
|
318,325
|
|
|
$4.50-$5.39
|
|
4.85
|
|
|
|
|
|
|
|||
|
Exercised
|
(101,575
|
)
|
|
$1.20-$2.60
|
|
|
1.59
|
|
|
|
|
|
|
||
|
Canceled and forfeited
|
(8,425
|
)
|
|
$0.12-$4.50
|
|
|
3.52
|
|
|
|
|
|
|
||
|
Expired
|
—
|
|
|
—
|
|
|
—
|
|
|
|
|
|
|
||
|
Outstanding, December 31, 2014
|
1,356,325
|
|
|
$1.20-$5.39
|
|
|
$
|
2.77
|
|
|
5.12 years
|
|
$
|
3,618,935
|
|
|
Exercisable, December 31, 2014
|
863,552
|
|
|
|
|
|
$
|
2.65
|
|
|
|
|
$
|
2,287,760
|
|
|
Vested and expected to vest, December 31, 2014
|
1,356,325
|
|
|
|
|
|
$
|
2.77
|
|
|
|
|
$
|
3,618,935
|
|
|
Stock option awards:
|
2014
|
|
2013
|
|
Expected life
|
6.25 years
|
|
5.63 years
|
|
Risk-free interest rate
|
1.51%
|
|
1.34%
|
|
Expected volatility
|
22.7%-32.3%
|
|
26.5%-36.1%
|
|
|
Number of
Restricted
Stock
|
|
Weighted
Average
Grant Date
Fair Value
|
|||
|
Unvested, December 31, 2013
|
361,570
|
|
|
$
|
1.31
|
|
|
Granted
|
—
|
|
|
—
|
|
|
|
Vested
|
(205,720
|
)
|
|
1.36
|
|
|
|
Forfeited
|
7,500
|
|
|
2.60
|
|
|
|
Unvested, December 31, 2014
|
163,350
|
|
|
$
|
1.31
|
|
|
Common Stock Options
|
Number of
Options
|
|
Exercise
Price Per
Share
|
|
Weighted
Average Exercise
Price
|
|
Weighted
Average Remaining
Life
|
|
Aggregate
Intrinsic
Value
|
||||||
|
Outstanding, December 31, 2013
|
575,000
|
|
|
$0.10-$0.50
|
|
|
$
|
0.29
|
|
|
6.44 years
|
|
$
|
120,000
|
|
|
Granted
|
100,000
|
|
|
0.50
|
|
|
0.50
|
|
|
|
|
|
|
||
|
Exercised
|
—
|
|
|
—
|
|
|
—
|
|
|
|
|
|
|
||
|
Canceled and forfeited
|
—
|
|
|
—
|
|
|
—
|
|
|
|
|
|
|
||
|
Expired
|
—
|
|
|
—
|
|
|
—
|
|
|
|
|
|
|
||
|
Outstanding, December 31, 2014
|
675,000
|
|
|
$0.10-$0.50
|
|
|
$
|
0.32
|
|
|
6.56 years
|
|
$
|
120,000
|
|
|
Exercisable, December 31, 2014
|
193,750
|
|
|
|
|
|
$
|
0.50
|
|
|
|
|
$
|
—
|
|
|
Vested and expected to vest, December 31, 2014
|
675,000
|
|
|
|
|
|
$
|
0.32
|
|
|
|
|
$
|
120,000
|
|
|
Stock option awards:
|
|
|
Expected life
|
6.25 years
|
|
Risk-free interest rate
|
1.65%
|
|
Expected volatility
|
35.2%
|
|
|
Number of
Restricted
Stock
|
|
Weighted
Average
Grant Date
Fair Value
|
|||
|
Unvested, December 31, 2013
|
310,000
|
|
|
$
|
0.10
|
|
|
Granted
|
—
|
|
|
—
|
|
|
|
Vested
|
—
|
|
|
—
|
|
|
|
Forfeited
|
—
|
|
|
—
|
|
|
|
Unvested, December 31, 2014
|
310,000
|
|
|
$
|
0.10
|
|
|
•
|
John N. Hatsopoulos, the Company’s Chief Executive Officer who is also: (a) the Chief Executive Officer and a director of American DG Energy and holds
19.4%
of American DG Energy’s common stock; (b) the Chairman of EuroSite Power and holds
4.7%
of EuroSite Power’s common stock; and (c) a director of Ilios and holds
7.2%
of Ilios’ common stock.
|
|
•
|
Dr. George N. Hatsopoulos, who is John N. Hatsopoulos’ brother, and is also: (a) an investor of American DG Energy and holds
13.0%
of American DG Energy’s common stock; (b) an investor in Eurosite Power and holds
0.7%
of EuroSite Power’s common stock; (c) an investor in Ilios and holds
3.1%
of Ilios' common stock; and (d) was a director of Tecogen until June 25, 2014.
|
|
•
|
Barry J. Sanders, who until February 6, 2015 was: (a) the President and Chief Operating Officer of American DG Energy, (b) the Chief Executive Officer and a director of EuroSite Power and (c) the Chairman of Ilios.
|
|
Inventory
|
|
$
|
17,400
|
|
|
Machinery and equipment
|
|
171,910
|
|
|
|
Computer equipment
|
|
22,070
|
|
|
|
Tooling
|
|
5,550
|
|
|
|
Developed technology
|
|
240,000
|
|
|
|
Goodwill
|
|
40,870
|
|
|
|
Total purchase consideration
|
|
$
|
497,800
|
|
|
|
2014
|
|
2013
|
||||
|
Benefit at federal statutory tax rate
|
$
|
1,319,500
|
|
|
$
|
1,280,000
|
|
|
Unbenefited operating losses
|
(1,319,500
|
)
|
|
(1,280,000
|
)
|
||
|
Income tax provision
|
$
|
—
|
|
|
$
|
—
|
|
|
|
2014
|
|
2013
|
||||
|
Net operating loss carryforwards
|
$
|
6,356,000
|
|
|
$
|
4,850,000
|
|
|
Accrued expenses and other
|
1,051,000
|
|
|
598,000
|
|
||
|
Accounts receivable
|
19,000
|
|
|
40,000
|
|
||
|
Inventory
|
207,000
|
|
|
117,000
|
|
||
|
Property, plant and equipment
|
138,000
|
|
|
155,000
|
|
||
|
Deferred tax assets
|
7,771,000
|
|
|
5,760,000
|
|
||
|
Valuation allowance
|
(7,771,000
|
)
|
|
(5,760,000
|
)
|
||
|
Deferred tax assets, net
|
$
|
—
|
|
|
$
|
—
|
|
No information found
* THE VALUE IS THE MARKET VALUE AS OF THE LAST DAY OF THE QUARTER FOR WHICH THE 13F WAS FILED.
| FUND | NUMBER OF SHARES | VALUE ($) | PUT OR CALL |
|---|
| DIRECTORS | AGE | BIO | OTHER DIRECTOR MEMBERSHIPS |
|---|
No information found
No Customers Found
No Suppliers Found
Price
Yield
| Owner | Position | Direct Shares | Indirect Shares |
|---|